Novo Nordisk has said a real-world survey of its weight-loss therapy Wegovy shows it can reduce 'food noise', persistent, ...

AstraZeneca's immunotherapy Imfinzi is the first drug therapy to be recommended for routine NHS use as a treatment for ...

FDA Commissioner Marty Makary has called direct-to-consumer (DTC) advertising of pharmaceuticals a "public health crisis" in ...

They join the seven current members of the ACIP, which is due to meet on the 18th and 19th of September to make ...

Additionally, AI-powered imaging can play a pivotal role in active surveillance programs, where low-risk prostate cancer ...

Rick Coope is General Manager at Menarini Stemline UK, Ireland, and the Nordics. With nearly 30 years of experience in ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk ...

Onsite in Princeton, New Jersey for the Axtria Ignite 2025 conference, web editor Nicole Raleigh spoke with Ritesh Mehra, CFO ...

Last October, Novartis paid $150 million upfront to Monte Rosa – with up to $2.1 billion at the back end – for an ...

Swedish biotech Camurus is reportedly in talks to acquire its US partner Braeburn Pharma in a deal that would give it full ...

AbbVie group companies have sought to block a state law (HB 728) requiring it to provide the discounts to contract pharmacies ...

An accompanying study of the high dose in adults with a BMI of 30 or more and type 2 diabetes, STEP UP T2D, has also been ...